✦ LIBER ✦

Risk adapted chemotherapy for localised Ewing’s sarcoma of bone: The French EW93 study

✍ Scribed by Nathalie Gaspar; Annie Rey; Perrine Marec Bérard; Jean Michon; Jean Claude Gentet; Marie Dominique Tabone; Henri Roché; Anne Sophie Defachelles; Odile Lejars; Emmanuel Plouvier; Claudine Schmitt; Binh Bui; Patrick Boutard; Sophie Taque; Martine Munzer; Jean-Pierre Vannier; Dominique Plantaz; Natacha Enz-Werlé; Odile Oberlin

Book ID: 116431101
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 981 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2012.03.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Risk adapted chemotherap

Corrigendum to “Risk adapted chemotherapy for localised Ewing’s sarcoma of bone: The French EW93 study” [Eur. J. Cancer 48 (9) (2012) 1376–1385]

✍ Gaspar, Nathalie; Rey, Annie; Bérard, Perrine Marec; Michon, Jean; Gentet, Jean 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Neoadjuvant chemotherapy for Ewing's sar

Neoadjuvant chemotherapy for Ewing's sarcoma of bone : No benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase-Results of two sequential studies

✍ Gaetano Bacci; Piero Picci; Stefano Ferrari; Mario Mercuri; Adalberto Brach del 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

27%) underwent surgery followed by radiation therapy, and 38 (46%) received topedico Rizzoli,

Neo-adjuvant chemotherapy alone or with

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

✍ Rolf D Issels; Lars H Lindner; Jaap Verweij; Peter Wust; Peter Reichardt; Baard- 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 395 KB

Performance status is the most powerful

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

✍ Penel, N; Glabbeke, M V; Mathoulin-Pelissier, S; Judson, I; Sleijfer, S; Bui, B; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 356 KB

Proteins, Dietary Acid Load, and Calcium

Proteins, Dietary Acid Load, and Calcium and Risk of Postmenopausal Fractures in the E3N French Women Prospective Study

✍ Patricia Dargent-Molina; Sèverine Sabia; Mathilde Touvier; Emmanuelle Kesse; Gér 📂 Article 📅 2008 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 78 KB

Phase III study to evaluate the use of h

Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208

✍ Yutaka Tokuda; Tomoo Tajima; Masaru Narabayashi; Kunihiko Takeyama; Toru Watanab 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB